Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children

Leukemia and Lymphoma

Volumn 54, Issue 2, 2013, Pages 381-386

  Wang, Dao ^a,b   Lv, Yan Qi ^c   Liu, Yu Feng ^a,b   Du, Xing Jun ^a,b   Li, Bai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b Pediatric Hematology and Oncology Institute   (China)

^c ZHENGZHOU CHILDREN S HOSPITAL   (China)

Author keywords

Acute lymphoblastic leukemia; Child; Mass spectrum; Proteomics; Two dimensional gel electrophoresis

Indexed keywords

60S ACIDIC RIBOSOMAL PROTEIN P0; ACTIN; CYTOPLASMIC ACTIN; GLUTATHIONE TRANSFERASE P1; PEROXIREDOXIN 4; PROHIBITIN; RIBOSOME PROTEIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN CELL; ISOELECTRIC POINT; LYMPHOCYTE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCHOOL CHILD; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DATABASES, PROTEIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; LYMPHOCYTES; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84872007955     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.713104     Document Type: Article

References (40)

1. Miron I, Ivanov A, Ivanov I, et al. Detection of fusion gene-integral part of the assessment of children with acute leukemia. Rev Med Chir Soc Med Nat Iasi 2011; 115: 731-735.
2. Harrison CJ. Acute lymphoblastic leukemia. Clin Lab Med 2 011; 31: 631-647.
3. Kwieci ń ska K, Balwierz W, Moryl-Bujakowska A, et al. long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified " New York " protocols (1987-2003). Przegl Lek 2010; 67: 350-354.
4. Li G, Xiao Z, Liu J, et al. Cancer: aproteomic disease. Sci China Life Sci 2011; 54: 403-408.
5. Banks RE, Dunn MJ, Hochstrasser DF, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000; 356: 1749-1756.
6. Blueggel M, Chamrad D, Meyer HE. Bioinformatics in proteomics. Curr Pharm Biotechnol 2004; 5: 79-88.
7. Hoeben A, Landuyt B, Botrus G, et al. Proteomics in cancer research: methods and application of array-based protein profiling technologies. Anal Chim Acta 2006; 564: 19-33.
8. Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997; 69: 4751-4760.
9. Chaurand P, Schwartz SA, Caprioli RM. Imaging mass spectrometry: anew tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 2002; 6: 676-681.
10. McDonnell LA, Corthals GL, Willems SM, et al. Peptide and protein imaging mass spectrometry in cancer research. JProteomics 2010; 73: 1921-1944.
11. Burns P, Armitage JO, Frey AL, et al. Analysis of the presenting features of adult acute leukemias:the French-American-British classification. Cancer 1981; 47: 2460-2469.
12. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with folin phenol reagent. JBiol Chem 1951; 193: 265-275.
13. G ö rg A, Obermaier C, Boguth G, et al. Thecurrent state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000; 21: 1037-1053.
14. Farias-Eisner R, Reddy ST. Biomarkers for early detection of ovarian cancer. US Patent 2010; 7: 670-792.
15. Hayashi N, Kuruma H, Egawa S. New marker proteins for prostate cancer. Nihon Rinsho 2011; 69: 140-144.
16. Barderas R, Babel I, Casal JI. Colorectal cancer proteomics, molecular characterization and biomarker discovery. Proteomics Clin Appl 2010; 4: 159-178.
17. Whitbread AK, Masoumi A, Tetlow N, et al. Characterization of the omega class of glutathione transferases. Methods Enzymol 2005; 401: 78-99.
18. He S, Liao TT, Chen YT, et al. Glutathione-S-transferase enhances proliferation-migration and protects against shikonininduced cell death in breast cancer cells. Kaohsiung JMed Sci 2011; 27: 477-484.
19. Wang Z, He W, Yang G, et al. Decreased expression of GST pi is correlated with apoor prognosis in human esophageal squamous carcinoma. BMC Cancer 2010; 10: 352.
20. Saip R, Sen F, Vural B, et al. Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients. JBUON 2011; 16: 241-246.
21. Ho T, Zhao C, Zheng R, et al. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: acasecontrol analysis. Arch Otolaryngol Head Neck Surg 2006; 132: 756-761.
22. Pasello M, Michelacci F, Scionti I, et al. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. Cancer Res 2008; 68: 6661-6668.
23. Bryzgunova OE, Morozkin ES, Yarmoschuk SV, et al. Methylationspecificsequencing of GSTP1 gene promoter in circulating/extra cellular DNA from blood and urine of healthy donors and prostate cancer patients. Ann NY Acad Sci 2008; 1137: 222-225.
24. Sutoh I, Kohno H, Nakashima Y, et al. Concurrent expressions of metallothionein, glutathione S-transferase-pi, and P-glycoprotein in colorectal cancers. Dis Colon Rectum 2000; 43: 221-232.
25. Den Boer ML, Pieters R, Kazemier KM, et al. Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia. Br JHaematol 1999; 104: 321-327.
26. Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 2002; 12: 655-658.
27. Xu Z, Wu J, Zha X. Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells. Sci China Life Sci 2011; 54: 121-127.
28. Wong PF, Cheong WF, Shu MH, et al. Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine 2012; 19: 138-144.
29. Jia L, Yi XF, Zhang ZB, et al. Prohibitin as anovel target protein of luteinizing hormone in ovarian epithelial carcinogenesis. Neoplasma 2011; 58: 104-109.
30. Chen D, Chen F, Lu X, et al. Identification of prohibitin as apotential biomarker for colorectal carcinoma based on proteomics technology. Int JOncol 2010; 37: 355-365.
31. Basu A, Banerjee H, Rojas H, et al. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 2011; 71: 755-765.
32. Li M, Lin YM, Hasegawa S, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int JOncol 2004; 24: 305-312.
33. Palande KK, Beekman R, van der Meeren LE, et al. Theantioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. PLoS One 2011; 6: e16340.
34. Jang JS, Cho HY, Lee YJ, et al. Thedifferential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 2004; 14: 491-499.
35. Jin DY, Chae HZ, Rhee SG, et al. Regulatory role for anovel human thioredoxin peroxidase in NF-kappaB activation. JBiol Chem 1997; 272: 30952-30961.
36. Chang TW, Chen CC, Chen KY, et al. Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells. Oncogene 2008; 27: 332-338.
37. Chen Y, Lin MC, Wang H, et al. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics 2007; 7: 3097-3104.
38. Schmitt-Gr ä ffA, Chaponnier C, Gabbiani G. Cytoskeletal organization of peripheral blood normal and leukemic lymphocytes and lymphoblasts. JSubmicrosc Cytol 1987; 19: 329-335.
39. Valera VA, Li-Ning TE, Walter BA, et al. Protein expression profiling in the spectrum of renal cell carcinomas. JCancer 2010; 1: 184-196.
40. Zhang XZ, Xiao ZF, Li C, et al. Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci 2009; 100: 2396-2401.